1 Min Read
Feb 21 (Reuters) - Roche Holding Ag
* Says receives eu approval of alecensa (alectinib) for people with previously treated alk-positive non-small cell lung cancer Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.